The company had posted net profit of Rs 113 crore for the July-September quarter of last fiscal, 2013-14, Torrent said in a filing to BSE.
Consolidated total income of the company in Q2, 2014-15 rose to Rs 1,217 crore as against Rs 972 crore in the year-ago period.
The Torrent Pharma scrip closed at Rs 922.25, up 1.31 per cent, on the BSE.